Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ROTEM Guided and Hemostatic Drugs Algorithms vs Standard Coagulation Test and Hemocomponent for Massive Obstetric Hemorrhage

NCT03784794 is registered in ClinicalTrials.gov with Angel Augusto Perez Calatayud as lead sponsor.

NCT NCT03784794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03784794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ROTEM Guided and Hemostatic Drugs Algorithms vs Standard Coagulation Test and Hemocomponent for Massive Obstetric Hemorrhage
Lead sponsor
Angel Augusto Perez Calatayud
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2018
Completion date
December 30, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrinogen; deficiency, acquired, fibrinogenolysis; hemorrhage, massive hemorrhage, post partum hemorrhage, transfusion related complication